No abstract available
MeSH terms
-
Adult
-
Antineoplastic Agents, Alkylating / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bendamustine Hydrochloride
-
Busulfan / administration & dosage
-
Busulfan / analogs & derivatives
-
Busulfan / therapeutic use
-
Clinical Trials, Phase II as Topic
-
Clinical Trials, Phase III as Topic
-
Combined Modality Therapy
-
Dacarbazine / administration & dosage
-
Dacarbazine / analogs & derivatives
-
Dacarbazine / pharmacokinetics
-
Dacarbazine / therapeutic use
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Embolization, Therapeutic
-
Eye Enucleation
-
Gemcitabine
-
Humans
-
Hyperthermia, Induced / methods
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary
-
Liver Neoplasms / therapy
-
Melanoma / drug therapy*
-
Melanoma / genetics
-
Melanoma / secondary
-
Melanoma / surgery
-
Melanoma / therapy
-
Middle Aged
-
Multicenter Studies as Topic
-
Nitrogen Mustard Compounds / therapeutic use
-
Nitrosourea Compounds / pharmacokinetics
-
Nitrosourea Compounds / therapeutic use
-
Organophosphorus Compounds / pharmacokinetics
-
Organophosphorus Compounds / therapeutic use
-
Prognosis
-
Retrospective Studies
-
Temozolomide
-
Uveal Neoplasms / drug therapy*
-
Uveal Neoplasms / genetics
-
Uveal Neoplasms / surgery
Substances
-
Antineoplastic Agents, Alkylating
-
Nitrogen Mustard Compounds
-
Nitrosourea Compounds
-
Organophosphorus Compounds
-
Deoxycytidine
-
Dacarbazine
-
Bendamustine Hydrochloride
-
treosulfan
-
Busulfan
-
fotemustine
-
Temozolomide
-
Gemcitabine